Abstract
Agouti-related peptide is expressed in the hypothalamic neurons in humans and animals. Immunohistochemical studies in Wistar rats shows significant changes in the optical density of agouti-related peptide in the neurons of the arcuate hypothalamic nucleus, as well as in their processes in the hypothalamus and nucleus accumbens after 6 h of sleep deprivation (an increase) and after 2 h of post-deprivative sleep (a decrease). Comparison of these findings with the earlier results shows the opposite trends in the changes in the optical density of agouti-related peptide and the speed of the limiting enzyme of dopamine synthesis, tyrosine hydroxylase, in the hypothalamus and in the striatonigral system. An increase in the agouti-related peptide level was accompanied by a decrease in tyrosine hydroxylase, while a decrease in agouti-related peptide, on the contrary, was accompanied by an increase in the tyrosine hydroxylase activity. Our data show the role played by agouti-related peptide as a modulator of the functional activity of the dopaminergic brain neurons. The interrelation between various functions of the body, such as food behavior, sleep, and stress, is considered to be mediated by the participation of the same neurotransmitter systems in their regulation.
Similar content being viewed by others
References
Ollmann, M., Wilson, B., Yang, Y., Kerns, J., Chen, Y., Gantz, I., and Barsh, G., Effects of recombinant agouti-signaling protein on melanocortin action, Science, 1997, vol. 278, p. 135.
Siljee, J.E., Unmehopa, U.A., Kalsbeek, A., Swaab, D.F., Fliers, E., and Alkemade, A., Melanocortin 4 receptor distribution in the human hypotthalamus, Eur. J. Endocrinol., 2013, vol. 168, no. 3, p. 361.
Bagnol, D., Lu, X.Y., Kaelin, C.B., Day, H.E., Olmann, M., Gantz, I., Barsh, G.S., and Watson, S.J., Anatomy of an endogenous antagonist: relationship between agouti-related protein and proopiomelanocortin in brain, J. Neurosci., 1999, vol. 19, p. 1.
Yang, Y.K., Ollmann, M., Wilson, B., Dickinson, C., Yamada, T., Barsh., and Gantz, I., Effects of recombinant agouti-signaling protein on melanocortin action, Mol. Endocrinol., 1997, vol. 11, p. 274.
Goldstone, A.P., Unmehopa, U.A., Bloom, S.R., and Swaab, D.F., Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects, J. Clin. Endocrinol. Metab., 2002, vol. 87, no. 2, p. 927.
Tolle, V. and Low, M.J., In vivo evidence for inverse agonism of agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice, Diabetes, 2008, vol. 57, no. 1, p. 86.
Pritchard, L.E. and White, A., Agouti-related protein: More than a melanocortin-4 receptor antagonist?, Peptides, 2005, vol. 26, p. 1759.
Romanova, I.V., The role of CART and AGRP in modulation of functional activity of dopaminergic neurons of the brain, Extended Abstract of Doctoral (Med.) Dissertation, St. Petersburg, 2012, 42 p.
Ugryumov, M.V., Mekhanizmy neiroendokrinnoi regulyatsii (Mechanisms of Neuroendocrinal Regulation), Moscow: Nauka, 1999.
Charbonneau, C., Bai, F., Richards, B.S., and Argyropoulos, G., Central and peripheral interactions between the agouti-related protein and leptin, Biochem. Biophys. Res. Commun., 2004, vol. 319, no. 2, p. 518.
Oganesyan, G.A., Aristakesyan, E.A., Belova, V.A., Artamokhina, I.V., and Romanova, I.V., Dopaminergic nigrostriatal system during sleep deprivation in rats, Ross. Fiziol. Zh. im. I. M. Sechenova, 2007, vol. 93, no. 12, p. 1344.
Oganesyan, G.A., Romanova, I.V., Aristakesyan, E.A., Kuzik, V.V., Makina, D.M., Morina, I. Yu., Khramenkova, A.V., Artamokhina, I.V., and Belova, V.A., Diencephalon-telencephalon changes of the activity of tyrosine hydroxylase in rats and grass frogs during sleep deprivation, Zh. Evol. Biokhim. Fiziol., 2008, vol. 44, no. 3, p. 250.
Paxinos, G. and Watson, Ch., The Rat Brain in Stereotaxic Coordinates, San Diego: Academic Press, 1998, 4th edition.
Kheriet, E.R. and Gatter, K.S., Immunocytichemistry: Optical microscopy, in Molekulyarnaya klinicheskaya diagnostika. Metody (Molecular Clinic Diagnostics: Methods), Moscow, 1999, p. 20.
Gvilia, I., Turner, A., McGinty, D., and Szymusiak, R., Preoptic area neurons and the homeostatic regulation of rapid eye movement sleep, J. Neurosci., 2006, vol. 26, p. 3037.
Koval’zon, V.M., Osnovy somnologii. Fiziologiya i neirokhimiya tsikla bodrstvovanie-son mlekopitayushchikh (The Basics of Somnology. Physiology and Neurochemistry of the Sleep-Wakefulness Cycle in Mammals), Moscow: Binom: Laboratoriya Znanii, 2011.
Koban, M., Le, W.W., and Hoffman, G.E., Changes in hypothalamic corticotropin-releasing hormone, neuropeptide Y, and proopiomelanocortin gene expression during chronic rapid eye movement sleep deprivation of rats, Endocrinology, 2006, vol. 147, no. 1, p. 421.
Ranjbaran, Z., Keefer, L., Stepanski, E., Farhadi, A., and Keshavarzian, A., The relevance of sleep abnormalities to chronic inflammatory conditions, Inflamm. Res., 2007, vol. 56, no. 2, p. 51.
Guo, J.S., Chau, J.F.L., Cho, C.H., and Koo, M.W.L., Partial sleep deprivation compromises gastric mucosal integrity in rats, Life Sci., 2005, vol. 77, no. 2, p. 220.
Stanley, S.A., Small, C.J., Murphy, K.G., Murphy, K.G., Rayes, E., Abbot, C.R., Seal, L.G., Morgan, D.G., Sunter, D., Dakin, C.L., Kim M.S., Hunter, R., Kuhar, M., Ghatei, M.A., and Bloom, S.R., Actions of cocaine- and amphetamine-regulated transcript (cart) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats, Brain Res., 2001, vol. 893, p. 186.
Schwartz, M.W. and Morton, G.J., Obesity: keeping hunger at bay, Nature, 2002, vol. 418, p. 595.
Koban, M., Sita, L.V., Le W.W., and Hoffman G.E., Sleep deprivation of rats: the hyperphagic response is real, Sleep, 2008, vol. 31, no. 7, p. 927.
Romanova, I.V., Morphofunctional interaction of the CART-peptide and dopaminergic neurons of the brain, Zh. Evol. Biokhim. Fiziol., 2013, vol. 49, no. 1, p. 78.
Smith, S.M., Vaughan, J.M., Donaldson, C.J., Rivier, J., Li, C., Chen, A., and Vale, W.W., Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism, J. Endocrinology, 2004, vol. 145, no. 11, p. 5202.
Stanley, S.A., Murphy, K.G., Bewick, G.A., Kong, W.M., Opacka-Juffry, J., Gardiner, J.V., Ghatei, M., Small, S.G., and Bloom, S.R., Regulation of rat pituitary cocaine- and amphetamine-regulated transcript (CART) by CRH and glucocorticoids, Am. J. Physiol. Endocrinol. Metab., 2004, vol. 287, no. 3, p. E583.
Bazhan, N.M., Makarova, E.N., Shevchenko, A.Yu., and Yakovleva, T.V., Repeated emotional stress obstacles the development of melanocortin-related obesity and type-2 diabetes in Agouti yellow-mutant mice, Ros. Fiziol. Zh. im. I.M. Sechenova, 2007, vol. 93, no. 11, p. 560.
Romanova, I.V., Chesnokova, A.Yu., and Mikhrina, A.L., Immunohistochemical study on CART-peptide in the striatonigral projections under dopamine-deficient conditions, Ros. Fiziol. Zh. im. I.M. Sechenova, 2012, vol. 98, no. 8, p. 980.
Author information
Authors and Affiliations
Additional information
Original Russian Text © I.V. Romanova, A.L. Mikhrina, 2013, published in Fiziologiya Cheloveka, 2013, Vol. 39, No. 6, pp. 24–30.
Rights and permissions
About this article
Cite this article
Romanova, I.V., Mikhrina, A.L. Participation of agouti-related peptide in the regulation of the wakefulness-sleep cycle. Hum Physiol 39, 584–589 (2013). https://doi.org/10.1134/S0362119713060108
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0362119713060108